PTJ
KYTH

Paul Tudor Jones’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Paul Tudor Jones’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,939
Closed -$523K – 1908
2015
Q2 		$523K Buy
+6,939
New +$372K 0.02% 748

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Paul Tudor Jones's KYTH Position: Q3 2015 in Review

Paul Tudor Jones sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 6,939 shares — an estimated $523K sold.

Paul Tudor Jones first reported a position in KYTH in Q2 2015 and held it in 1 quarter. The position peaked at $523K in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

  • Paul Tudor Jones reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
  • Paul Tudor Jones sold 6,939 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $523K.
  • Paul Tudor Jones first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 1 quarter.
  • Paul Tudor Jones's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $523K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Tudor Investment Corp's 13F filing for Q3 2015, filed 16 Nov 2015.